A new type of defibrillator met safety, effectiveness goals in global clinical study

ROCHESTER, Minn. — A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular a rrhythmias. The findings were presented during a late-breaking session at the European Society of Cardiology Congress and were simultaneously published in The New England Journal of Medicine. Arrhythmias such as ventricular fibrillation and…
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news